FZD9 is unique among Frizzled receptors in that it does not activate oncogenic signaling pathways in lung cancer but contributes to maintenance of a normal lung epithelium and exerts tumor suppressive effects when partnered with Wnt7a or iloprost1,2,4. Here, WNT7A is linked to lung carcinoma.